The management of lumbar radicular pain has evolved considerably in recent years, with increasing emphasis on individualising treatment strategies to address both the peripheral and central ...

In a review and meta-analysis, serious spinal pathologies accounted for 3% of cases of LBP, with higher rates in complex care settings.

Vertex Pharmaceuticals Incorporated stands second on our list and has recently launched the first non opioid acute pain treatment.

A recent study has linked gabapentin, a popular painkiller for lower back pain, to increased risk of dementia and mild cognitive impairment in some adults.

This news must have been a hard pill to swallow. There is a nationwide shortage of common prescription pain medications in Canada — and it could last until early August. Opioids that contain ...

In July 2025, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) launched JOURNAVX (suzetrigine), a first-in-class, non-opioid treatment for moderate-to-severe acute pain.

WebMD provides a rundown of specialists who diagnose and treat pain, along with information on finding one near you.

Keep your joints moving smoothly with hyaluronic acid supplements. Explore the 8 best picks for pain-free movement.  ...

Chronic fatigue syndrome. Read the latest research news on chronic fatigue syndrome (CFS).

Cleveland's Today in Ohio podcast argues stockholders—not customers—should bear the financial burden of FirstEnergy's historic corruption scandal, forcing owners to demand change from within.

The University of Southern Mississippi (USM) has a new Coastal Pathways Scholarship for students at Pearl River Community College.

A look at the day ahead in European and global markets from Ankur Banerjee ...